Korean J Hematol 2012; 47(2):
Published online June 26, 2012
https://doi.org/10.5045/kjh.2012.47.2.92
© The Korean Society of Hematology
Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Correspondence to : Correspondence to Jooryung Huh, M.D., Ph.D., Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Seoul 138-736, Korea. Tel: +82-2-3010-4560, Fax: +82-2-472-7898, jrhuh@amc.seoul.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Malignant lymphoma encompasses a wide variety of distinct disease entities. It is generally more common in developed countries and less common in developing countries. The East Asia region has one of the lowest incidence rates of malignant lymphoma. The incidence of malignant lymphoma around the world has been increasing at a rate of 3-4% over the last 4 decades, while some stabilization has been observed in developed countries in recent years. The reasons behind this lymphoma epidemic are poorly understood, although improving diagnostic accuracy, the recent AIDS epidemic, an aging world population and the increasing adoption of cancer-causing behaviors are suggested as contributing factors. Etiologies of malignant lymphoma include infectious agents, immunodeficiency, autoimmune disease, exposure to certain organic chemicals, and pharmaceuticals. The distribution of many subtypes exhibit marked geographic variations. Compared to the West, T/natural killer (NK) cell lymphomas (T/NK-cell lymphoma) and extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) are relatively more common, whereas other B-cell lymphomas, particularly follicular lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma, are less common in Asia. Some subtypes of T/NK-cell lymphomas defined by Epstein-Barr virus association are predominantly Asian diseases, if not exclusively so. Both ethnic and environmental factors play roles in such diversity. In this review, we discuss the geographic distribution and etiology of malignant lymphoma, as well as the trend.
Keywords Malignant lymphoma, Epidemiology, Asia
Korean J Hematol 2012; 47(2): 92-104
Published online June 26, 2012 https://doi.org/10.5045/kjh.2012.47.2.92
Copyright © The Korean Society of Hematology.
Jooryung Huh*
Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Correspondence to: Correspondence to Jooryung Huh, M.D., Ph.D., Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Seoul 138-736, Korea. Tel: +82-2-3010-4560, Fax: +82-2-472-7898, jrhuh@amc.seoul.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Malignant lymphoma encompasses a wide variety of distinct disease entities. It is generally more common in developed countries and less common in developing countries. The East Asia region has one of the lowest incidence rates of malignant lymphoma. The incidence of malignant lymphoma around the world has been increasing at a rate of 3-4% over the last 4 decades, while some stabilization has been observed in developed countries in recent years. The reasons behind this lymphoma epidemic are poorly understood, although improving diagnostic accuracy, the recent AIDS epidemic, an aging world population and the increasing adoption of cancer-causing behaviors are suggested as contributing factors. Etiologies of malignant lymphoma include infectious agents, immunodeficiency, autoimmune disease, exposure to certain organic chemicals, and pharmaceuticals. The distribution of many subtypes exhibit marked geographic variations. Compared to the West, T/natural killer (NK) cell lymphomas (T/NK-cell lymphoma) and extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) are relatively more common, whereas other B-cell lymphomas, particularly follicular lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma, are less common in Asia. Some subtypes of T/NK-cell lymphomas defined by Epstein-Barr virus association are predominantly Asian diseases, if not exclusively so. Both ethnic and environmental factors play roles in such diversity. In this review, we discuss the geographic distribution and etiology of malignant lymphoma, as well as the trend.
Keywords: Malignant lymphoma, Epidemiology, Asia
World map of the estimated age-standardized incidence rates (per 100,000 WHO world standard population) of non-Hodgkin lymphoma and Hodgkin lymphoma combined. Source: GLOBOCAN (http://globocan.iarc.fr/) from CANCER
Nominal gross domestic product (GDP) per capita world map 2008. Source: CIA World Factbook 2008. Abbreviation: PPP, purchasing power parity.
Trends in estimated age-standardized (world) incidence rates of non-Hodgkin lymphoma. Source: CI5plus in CANCER
Trends in estimated age-standardized (world) incidence rates of Hodgkin lymphoma. Source: CI5plus in CANCER
Age-specific incidence rates (ASR) of non-Hodgkin lymphoma and Hodgkin lymphoma in Korea in 2008. Source: Park et al. [8].
Age distribution of malignant lymphoma at diagnosis for 1989-2008 at Asan Medical Center. Source: Yoon et al. [7]. Abbreviations: CLL/SLL, chronic lymphocytic leukemia/small lymphocytic lymphoma; MCL, mantle cell lymphoma; FL, follicular lymphoma; MALT, mucosa-associated lymphoid tissue; DLBCL, diffuse large B-cell lymphoma; NK, natural killer; PTCL, peripheral T-cell lymphoma, not otherwise specified; NHL, non-Hodgkin lymphoma.
Table 1 . Incidence rates of malignant lymphoma in East Asia in 2008..
a)North Korea, b)Taiwan..
Age-standardized incidence rates/100,000 (WHO world standard population). GLOBOCAN 2008..
For Korea, data are from the Korea National Cancer Incidence Database..
Table 2 . Biologic agents implicated in malignant lymphomas [31]..
Abbreviations: AIDS, acquired immunodeficiency syndrome; CNS, central nervous system; DLBCL, diffuse large B-cell lymphoma; EBV, Epstein-Barr virus; HBV, hepatitis B virus; HCV, hepatitis C virus; HHV8, human herpesvirus 8; HIV, human immunodeficiency virus; LPD, lymphoproliferative disorder; MALT, mucosa-associated lymphoid tissue; MCD, multicentric Castleman disease; NHL, non-Hodgkin lymphoma..
Table 3 . Environmental carcinogens implicated in malignant lymphoma..
Abbreviations: ANLL, acute non-lymphocytic leukemia; ALL, acute lymphoblastic leukemia; CLL, chronic lymphocytic leukemia; MM, multiple myeloma; NHL, non-Hodgkin lymphoma..
Won-Ju Park, Joo-heon Park, Seunghyeon Cho, Myung Geun Shin
Blood Res 2021; 56(4): 301-314Jun Ho Yi, Gyeong-Won Lee, Ji Hyun Lee, Kwai Han Yoo, Chul Won Jung, Dae Sik Kim, Jeong-Ok Lee, Hyeon Seok Eom, Ja Min Byun, Youngil Koh, Sung Soo Yoon, Jin Seok Kim, Jee Hyun Kong, Ho-Young Yhim, Deok-Hwan Yang, Dok Hyun Yoon, Do Hyoung Lim, Won-Sik Lee, Ho-Jin Shin
Blood Res 2021; 56(4): 243-251Hyeon Gyu Yi, Jin Seok Kim, Cheolwon Suh, Won Seog Kim, Jae-Yong Kwak, Jong-Seok Lee, Yang Soo Kim, Young Don Joo, Yoo Hong Min, Hong Ghi Lee, Sung-Soo Yoon, Jong-Ho Won, Seonyang Park, Hugh Chul Kim, and Chul Soo Kim
Blood Res 2013; 48(2): 115-120
World map of the estimated age-standardized incidence rates (per 100,000 WHO world standard population) of non-Hodgkin lymphoma and Hodgkin lymphoma combined. Source: GLOBOCAN (http://globocan.iarc.fr/) from CANCER
Nominal gross domestic product (GDP) per capita world map 2008. Source: CIA World Factbook 2008. Abbreviation: PPP, purchasing power parity.
|@|~(^,^)~|@|Trends in estimated age-standardized (world) incidence rates of non-Hodgkin lymphoma. Source: CI5plus in CANCER
Trends in estimated age-standardized (world) incidence rates of Hodgkin lymphoma. Source: CI5plus in CANCER
Age-specific incidence rates (ASR) of non-Hodgkin lymphoma and Hodgkin lymphoma in Korea in 2008. Source: Park et al. [8].
|@|~(^,^)~|@|Age distribution of malignant lymphoma at diagnosis for 1989-2008 at Asan Medical Center. Source: Yoon et al. [7]. Abbreviations: CLL/SLL, chronic lymphocytic leukemia/small lymphocytic lymphoma; MCL, mantle cell lymphoma; FL, follicular lymphoma; MALT, mucosa-associated lymphoid tissue; DLBCL, diffuse large B-cell lymphoma; NK, natural killer; PTCL, peripheral T-cell lymphoma, not otherwise specified; NHL, non-Hodgkin lymphoma.